SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences Group is currently the top trending ticker as investors debate the impact of trial protocol modifications on its REGAL Phase 3 study and upcoming AACR presentation. While some community members highlight potential long-term clinical efficacy and a possible buyout, others express strong skepticism regarding the trial's design and management's transparency.

Maulcoin

Maulcoin is trending as its community actively rallies to defend the project's organic growth and transparency against perceived market manipulation and copycat tokens. Supporters are heavily focused on coordinating buying challenges to build a stronger price floor and establish the coin as a legitimate, community-led project.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Investors are rallying behind $RETIRE as a tokenized alternative to traditional retirement plans, positioning it as a movement against the established financial system. The community is actively building momentum through weekly dollar-cost averaging and frequent social media campaigns, driven by hopes for significant long-term growth and financial independence.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

The 401jK community is actively promoting its meme-centric narrative as a defiant alternative to traditional, broken retirement systems. Investors are debating the project's long-term utility versus its high volatility, while the community continues to focus on grassroots educational initiatives and widespread IRL marketing.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending due to intense volatility surrounding the company's transition from a single-product biotech to a vertically integrated oncology platform centered on its proprietary Anktiva and Leonardo systems. Investors are closely monitoring a pivotal near-term regulatory catalyst regarding the FDA sBLA acceptance for Anktiva's label expansion, while active community discourse remains focused on balancing the company's aggressive growth narrative against persistent regulatory friction and speculative short-selling activity.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates its position in AI infrastructure, with intense speculation surrounding its 800V-to-6V power delivery platforms and potential design wins with major hardware partners. Sentiment is sharply divided between bulls highlighting the company's energy-efficient GaN technology and long-term data center growth, and bears concerned about high valuation relative to current revenue and ongoing institutional short interest.

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Bicycle Therapeutics Plc - ADR

Bicycle Therapeutics is trending as investors focus on upcoming clinical data from the AACR conference, particularly concerning its lead asset BT5528 in combination studies. While community sentiment is divided between optimism regarding its strong cash runway and the potential of its radiopharma pivot versus concerns over past regulatory hurdles and pipeline restructuring, the stock remains a high-interest subject for those weighing binary biotech risk against a solid balance sheet.

Daddy Darth Vader

DARTH is currently driving intense community speculation amid a "daddy war" rivalry with $MAULCOIN, with participants actively debating the token's long-term viability versus its nature as a high-risk trading opportunity. While some investors focus on liquidity building and potential parabolic gains, others express strong skepticism, labeling the project a potential scam or pump-and-dump scheme.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened volatility and social media attention as traders monitor a potential short squeeze, fueled by high short interest and technical setups that resemble previous momentum plays in the rental car sector. The community is actively debating the stock's turnaround potential, with discussions focused on whether recent price action and institutional positioning indicate a structural reversal or merely speculative short-term volatility.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant market attention as investors highlight its strategic partnerships with NVIDIA and its development of quantum sensing technology for defense and space applications. The community is actively discussing the stock's potential for a valuation re-rating, often comparing its current market cap to other quantum sector peers while noting its recent inclusion in high-profile quantum AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clarus Group Inc. Sells 3,185 Shares of NVIDIA Corporation $NVDA

Clarus Group Inc. reduced its position in shares of NVIDIA Corporation (NASDAQ:NVDA - Free Report) by 7.6% during the fourth quarter, according to the company in its most recent 13F filing with the...

Clarus (NASDAQ:CLAR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of Clarus from a "sell" rating to a "hold" rating in a research report on Saturday...

Clarus (NASDAQ:CLAR)  Shares Down 1.1%   - Time to Sell?

Clarus (NASDAQ:CLAR) Shares Down 1.1% - What's Next...

FY2026 EPS Estimates for TSE:DCM Decreased by Analyst

DATA Communications Management Corp. (TSE:DCM - Free Report) - Clarus Securities reduced their FY2026 EPS estimates for DATA Communications Management in a research note issued on Friday, March 13th...

Clarus Corporation Announces Quarterly Dividend of $0.03 (NASDAQ:CLAR)

Clarus Corporation (NASDAQ:CLAR) declared a quarterly dividend on Friday, March 6th. Investors of record on Monday, March 16th will be paid a dividend of 0.025 per share on Wednesday, March 25th...

Clarus (NASDAQ:CLAR) Price Target Cut to $3.00 by Analysts at Lake Street Capital

Lake Street Capital reduced their price objective on shares of Clarus from $3.50 to $3.00 and set a "hold" rating for the company in a research note on Friday...

Roth Mkm Lowers Clarus (NASDAQ:CLAR) Price Target to $3.25

Roth Mkm decreased their target price on Clarus from $3.50 to $3.25 and set a "neutral" rating for the company in a research note on Friday...

Clarus Analysts Slash Their Forecasts After Q4 Earnings

Clarus Corp (NASDAQ:CLAR) reported mixed Q4 results, meeting earnings expectations but missing sales estimates. Shares fell 4.2% to $2.97. Analysts have lowered price targets for the stock.read more...

Clarus (NASDAQ:CLAR) Price Target Cut to $6.00 by Analysts at Stifel Nicolaus

Stifel Nicolaus decreased their target price on Clarus from $7.00 to $6.00 and set a "buy" rating for the company in a research report on Friday...

Q1 Earnings Forecast for TSE:FAR Issued By Clarus Securities

Foraco International SA (TSE:FAR - Free Report) - Investment analysts at Clarus Securities reduced their Q1 2026 earnings per share estimates for Foraco International in a report released on Tuesday...

Clarus Corp engages in the development, manufacture, and distribution of outdoor equipment and lifestyle products. It operates through Outdoor and Adventure segments. The Outdoor segment manufactures outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment sells automotive roof racks, trays, mounting systems, luggage boxes, carriers and accessories. The company was founded in 1989 and is headquartered in Salt Lake City, UT.

Current Price	$2.93
Prev Close	$2.81
Open	$2.85
Dividend Yield	2.99%
50-Day Moving Average	$2.99
Beta	1.10
Avg. Volume	262,445.45
PE Ratio	-2.42

52-Week High	$4.03
52-Week Low	$2.59
Market Capitalization	$107.91M
EPS (Annual)	-$1.21
Price to Book	0.57
Revenue Per Employee	$646,217.95

CLAR
Clarus Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLAR News

CLARClarus Corp